Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 117.05
-1.41 %
$ 11.7 B
Market Cap
35.58
P/E
NBIX - OPERATING INCOME
Operating Income NBIX - Neurocrine Biosciences, Inc.
570 M
LAST VALUE
51.37%
2 YEAR CAGR
21.09%
5 YEAR CAGR
26.93%
10 YEAR CAGR